Garvey 1 EKG Lecture RACE May 2013
... Department of Emergency Medicine Carolinas Medical Center ...
... Department of Emergency Medicine Carolinas Medical Center ...
Electrocardiographic effects of myocardial ischemia induced
... Fourteen seconds of electrocardiographic potentials were recorded. Signals were amplified by a bank of 87 low noise, differential (electrode versus Wilson central terminal potential) amplifiers (17). Gains were set at 1,000 to 16,000 under computer control so that the output filled the input range o ...
... Fourteen seconds of electrocardiographic potentials were recorded. Signals were amplified by a bank of 87 low noise, differential (electrode versus Wilson central terminal potential) amplifiers (17). Gains were set at 1,000 to 16,000 under computer control so that the output filled the input range o ...
ACUTE CORONARY SYNDROMES: Acute MI
... Subacute thrombotic occlusion after stent placement occurs in approximately 4% of pts 2 to 14 days after procedure – this less common than closure after angioplasty ...
... Subacute thrombotic occlusion after stent placement occurs in approximately 4% of pts 2 to 14 days after procedure – this less common than closure after angioplasty ...
Lipid Variables Related to the Extent and Severity of Coronary Artery
... to 5 using the following criteria for categorization: 0, no arteriographic abnormalities; 1, trivial irregularities (lesions with stenosis severity of 1–29%); 2, lesions with stenosis severity of 30–68%; 3, multiple narrowing in the same vessel, with the stenosed segment having either one lesion wit ...
... to 5 using the following criteria for categorization: 0, no arteriographic abnormalities; 1, trivial irregularities (lesions with stenosis severity of 1–29%); 2, lesions with stenosis severity of 30–68%; 3, multiple narrowing in the same vessel, with the stenosed segment having either one lesion wit ...
Steady-state free precession sequences in myocardial first
... et al. and is of the same order of magnitude [19]; however, the difference did not reach statistical significance in this small number of subjects. Visually, the distinction of certainly hypoperfused areas, i.e., infarction zone, in the patient portion of our study was easier in TrueFISP (Figs. 6, 7 ...
... et al. and is of the same order of magnitude [19]; however, the difference did not reach statistical significance in this small number of subjects. Visually, the distinction of certainly hypoperfused areas, i.e., infarction zone, in the patient portion of our study was easier in TrueFISP (Figs. 6, 7 ...
Direct Thrombin Inhibitors - New England Journal of Medicine
... benefit,32 a finding that was supported in a longerterm follow-up using an intention-to-treat analysis.33 The combined outcome of death, myocardial infarction, and revascularization at 7 and 90 days occurred less frequently with bivalirudin, mainly owing to an effect on the need for revascularizatio ...
... benefit,32 a finding that was supported in a longerterm follow-up using an intention-to-treat analysis.33 The combined outcome of death, myocardial infarction, and revascularization at 7 and 90 days occurred less frequently with bivalirudin, mainly owing to an effect on the need for revascularizatio ...
PHARMACEUTICAL ASPECTS OF NICORANDIL
... adenine nucleotides16. It has definite cardioprotective properties in acute myocardial ischemia. At higher concentrations, nicorandil appears to act through the NO group‐activated guanylate cyclase. While both pathways contribute to these effects, which are independent17 ...
... adenine nucleotides16. It has definite cardioprotective properties in acute myocardial ischemia. At higher concentrations, nicorandil appears to act through the NO group‐activated guanylate cyclase. While both pathways contribute to these effects, which are independent17 ...
cardiac catheterization laboratory
... We of the Cardiac Catheterization Laboratory at The Mount Sinai Hospital are proud to present our patient-centered 2015 outcomes report, a comprehensive overview of the work being done at one of the nation’s finest cardiac catheterization laboratories. Public reporting of quality outcomes and patien ...
... We of the Cardiac Catheterization Laboratory at The Mount Sinai Hospital are proud to present our patient-centered 2015 outcomes report, a comprehensive overview of the work being done at one of the nation’s finest cardiac catheterization laboratories. Public reporting of quality outcomes and patien ...
Flash pulmonary oedema and bilateral renal artery stenosis: the Pickering Syndrome †
... surgical and percutaneous revascularization techniques have been successful in treating RAS and its clinical manifestations such as FPO (Table 3).1 – 2,32,35 – 36,38,44 – 45,88 – 90 Renal revascularization decreases circulating angiotensin and aldosterone levels resulting in a fall in blood pressure ...
... surgical and percutaneous revascularization techniques have been successful in treating RAS and its clinical manifestations such as FPO (Table 3).1 – 2,32,35 – 36,38,44 – 45,88 – 90 Renal revascularization decreases circulating angiotensin and aldosterone levels resulting in a fall in blood pressure ...
coronary artery disease
... Mechanism Causes Clinical manifestation Complication Nursing care ...
... Mechanism Causes Clinical manifestation Complication Nursing care ...
coronary artery disease
... Mechanism Causes Clinical manifestation Complication Nursing care ...
... Mechanism Causes Clinical manifestation Complication Nursing care ...
Coronary Artery Calcification: Methods and Clinical Value
... Asymtomatic Individuals Efforts have been made to develop non-invasive diagnostic tools to help determine the extent of atherosclerosis in asymptomatic patients and improved detection of those who would benefit from more intensive preventive therapies such as lipid lowering medication and aspirin. T ...
... Asymtomatic Individuals Efforts have been made to develop non-invasive diagnostic tools to help determine the extent of atherosclerosis in asymptomatic patients and improved detection of those who would benefit from more intensive preventive therapies such as lipid lowering medication and aspirin. T ...
VIEW PDF - Glaucoma Today
... release. According to the company, the stent is the first glaucoma device to achieve an IOP reduction similar to traditional subconjunctival trabeculectomy and tube shunt procedures through a minimally invasive technique with less associated surgical and postoperative risk. The prospective, multicen ...
... release. According to the company, the stent is the first glaucoma device to achieve an IOP reduction similar to traditional subconjunctival trabeculectomy and tube shunt procedures through a minimally invasive technique with less associated surgical and postoperative risk. The prospective, multicen ...
Antiplatelet Drugs - OSU Center for Continuing Medical Education
... ischemic heart disease56 –58 (including after cardiac surgery59), it is suggested that, until further research is done, where possible, analgesic drugs with minimal effects on COX (e.g., acetaminophen42,56) be considered particularly in patients who have undergone a PCI procedure with stent placemen ...
... ischemic heart disease56 –58 (including after cardiac surgery59), it is suggested that, until further research is done, where possible, analgesic drugs with minimal effects on COX (e.g., acetaminophen42,56) be considered particularly in patients who have undergone a PCI procedure with stent placemen ...
the role of the drug regulatory agencies about the interaction
... What considerations can be made after a detailed reading of these documents? Initially we find it reasonable and positive that drug regulatory agencies publish their findings even in the absence of conclusive data. However, there are important questions that must be analyzed carefully. For example, ...
... What considerations can be made after a detailed reading of these documents? Initially we find it reasonable and positive that drug regulatory agencies publish their findings even in the absence of conclusive data. However, there are important questions that must be analyzed carefully. For example, ...
Acetylcysteine
... Acetylcysteine (an antioxidant) represents a safe, non-expensive , easy to administer, and widely available drug THE EVIDENCE Low quality (few trials with allocation concealment, blinding, and ITT analysis) Low statistical power (median trial size = 80 patients) Uncertain effects on clinical endpoin ...
... Acetylcysteine (an antioxidant) represents a safe, non-expensive , easy to administer, and widely available drug THE EVIDENCE Low quality (few trials with allocation concealment, blinding, and ITT analysis) Low statistical power (median trial size = 80 patients) Uncertain effects on clinical endpoin ...
CAROTID ARTERY STENTING - Vascular Health Center
... people may experience TIA or stroke. A stroke or “brain attack” is an injury to the brain caused by lack of oxygen. Stroke occurs in about 700,000 people a year in the United States. About 280,000 patients die each year from stroke-related causes. Transient ischemic attacks (TIAs), also called “temp ...
... people may experience TIA or stroke. A stroke or “brain attack” is an injury to the brain caused by lack of oxygen. Stroke occurs in about 700,000 people a year in the United States. About 280,000 patients die each year from stroke-related causes. Transient ischemic attacks (TIAs), also called “temp ...
What is a heart attack
... over many years) or stroke (sudden death of brain tissue). In many people, atherosclerosis can remain silent (causing no symptoms or health problems) for years or decades. Atherosclerosis can begin as early as the teenage years, but symptoms or health problems usually do not arise until later in adu ...
... over many years) or stroke (sudden death of brain tissue). In many people, atherosclerosis can remain silent (causing no symptoms or health problems) for years or decades. Atherosclerosis can begin as early as the teenage years, but symptoms or health problems usually do not arise until later in adu ...
Triumph of the trials
... "The concept that you convert to normal sinus rhythm and therefore off of anticoagulants is really a dream." I do Holter monitoring 3 months later because most patients you can see there are still a few beats of atrial ...
... "The concept that you convert to normal sinus rhythm and therefore off of anticoagulants is really a dream." I do Holter monitoring 3 months later because most patients you can see there are still a few beats of atrial ...
Scintigraphic perfusion defects due to right ventricular
... speckle-tracking strain imaging [10]. In addition, significantly reduced LV ejection fraction was observed as well as an impaired LV longitudinal shortening and reduced LV twist. Whether this acutely induced LV dyssynchrony is responsible for the further development of heart failure after long-term ...
... speckle-tracking strain imaging [10]. In addition, significantly reduced LV ejection fraction was observed as well as an impaired LV longitudinal shortening and reduced LV twist. Whether this acutely induced LV dyssynchrony is responsible for the further development of heart failure after long-term ...
infarct size
... effect of perfusion of the infarct artery on the relation between the extent of initial ST segment elevation and final electrocardiographic infarct size. The sum of the initial peak ST elevations in all leads correlated with electrocardiographic infarct size in patients with anterior infarction and ...
... effect of perfusion of the infarct artery on the relation between the extent of initial ST segment elevation and final electrocardiographic infarct size. The sum of the initial peak ST elevations in all leads correlated with electrocardiographic infarct size in patients with anterior infarction and ...
Heart Online First, published on December 30, 2005 as 10.1136/hrt.2005.077164
... remodeling, congestive heart failure, and poor prognosis [4-6]. Therefore, myocardial tissue perfusion is now accepted as a target of reperfusion therapy for AMI [7]. Specific platelet glycoprotein IIb/IIIa receptor inhibitor with powerful antiplatelet aggregation property has been found to attenuat ...
... remodeling, congestive heart failure, and poor prognosis [4-6]. Therefore, myocardial tissue perfusion is now accepted as a target of reperfusion therapy for AMI [7]. Specific platelet glycoprotein IIb/IIIa receptor inhibitor with powerful antiplatelet aggregation property has been found to attenuat ...
Prognosis of complete versus incomplete
... What is already known about this subject? ►► Whether incomplete revascularisation in patients ...
... What is already known about this subject? ►► Whether incomplete revascularisation in patients ...
Drug-eluting stent
A drug-eluting stent (DES) is a peripheral or coronary stent (a scaffold) placed into narrowed, diseased peripheral or coronary arteries that slowly releases a drug to block cell proliferation. This prevents fibrosis that, together with clots (thrombi), could otherwise block the stented artery, a process called restenosis. The stent is usually placed within the peripheral or coronary artery by an interventional cardiologist or interventional radiologist during an angioplasty procedure.Drug-eluting stents in current clinical use were approved by the FDA after clinical trials showed they were statistically superior to bare-metal stents for the treatment of native coronary artery narrowings, having lower rates of major adverse cardiac events (usually defined as a composite clinical endpoint of death + myocardial infarction + repeat intervention because of restenosis). The first drug-eluting stents to be approved in Europe and the U.S. were coated with paclitaxel or an mTOR inhibitor, such as sirolimus.